Researchers announced a phase 3 trial assessing secukinumab for the treatment of psoriatic arthritis met its primary endpoint (ACR 20 at week 24), possibly putting the drug on the fast track to approval.
The effect of the 1064-nm Q-switched Nd:YAG laser on tattoo removal varies with the amount of ink deposited in the tissue, according to a study published online July 2 in the Journal of Cosmetic Dermatology.
The non-economic damages cap under the Medical Injury Compensation Reform Act (MICRA) has been upheld again in a California court of appeal, according to a report published by the American Medical Association.
For many cancers, mortality rates are declining and are expected to meet Healthy People 2020 (HP2020) targets, according to a study published online July 2 in the US Centers for Disease Control and Prevention's Preventing Chronic Disease.
Coming next from Medicare: the ICD-10 Obmudsman. Billing under the dreaded new International Classification of Diseases-10 (ICD-10) coding system will get a bit less onerous under a deal brokered between Medicare and the American Medical Association.
An α-melanocyte-stimulating hormone analog, afamelanotide, is associated with reduced pain and improved quality of life in patients with erythropoietic protoporphyria, according to research published in the July 2 issue of the New England Journal of Medicine.